Last reviewed · How we verify
NCT05510440
Supplementation With Altha-aminoacids and Systemiec Inflammatory Response in Long-distance Runners.
NA trial testing Alpha-amino acid derivatives in Exercise Myoglobinuria in 60 participants. Status unknown.
1 May 2023
Quick facts
| Lead sponsor | Medical University of Gdansk |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | basic science |
| Enrollment | 60 |
| Start date | 1 March 2023 |
| Primary completion | 1 May 2023 |
| Estimated completion | 30 November 2023 |
| Sites | 2 locations across Poland |
Drugs / interventions tested
- Alpha-amino acid derivatives
Conditions studied
- Exercise Myoglobinuria — all drugs for Exercise Myoglobinuria →
- Citrulline; Metabolic Disorder — all drugs for Citrulline; Metabolic Disorder →
- Iron Metabolism Disorders — all drugs for Iron Metabolism Disorders →
- Inflammatory Response — all drugs for Inflammatory Response →
Sponsor
Medical University of Gdansk
Who can join
Adults 21 to 40, male only, with Exercise Myoglobinuria or Citrulline; Metabolic Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is also noteworthy that the imbalance between the production, supply and elimination of especially α-amino acids may contribute to the intensification of the inflammatory response and the subsequent burden of the renal tubules, which may result in damage and developing chronic renal failure. Among the many amino acids used in sports, arginine and its metabolites deserve special attention. The role of arginine appears to increase in specific physiological states associated with disease, injury or significant strain on the body, leading to an increase in the rate of catabolic transformation. Arginine plays a significant role in protein biosynthesis and detoxification processes related to ammonia removal and urea formation .
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05510440
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Medical University of Gdansk trials
Trials by the same sponsor.
- NCT07521280 — State-Based Rehabilitation for Youth Athletes With Osgood-Schlatter or Sever-Related Apophyseal Pain · NA · not yet recruiting
- NCT07446517 — Low-Level Laser Therapy for Osgood-Schlatter or Sever Pain in Youth Athletes · NA · recruiting
- NCT07449585 — Pericapsular Nerve Group Block Versus Intrathecal Morphine for Analgesia After Total Hip Arthroplasty · NA · not yet recruiting
- NCT07397208 — Assessment of the Repeatability of Sublingual Microcirculation Function Measurements in Healthy Volunteers and Criticall · not yet recruiting
- NCT07345403 — GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Ana · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05510440 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Gdansk
- Last refreshed: 4 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05510440.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing